EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Interleukin(IL)-37 attenuates isoproterenol (ISO)-induced cardiac hypertrophy by suppressing JAK2/STAT3-signaling associated inflammation and oxidative stress

Xiaohua Guo, Pengfei Wang, Huiqing Wei, Jie Yan, Donglei Zhang, Yuxing Qian, Bingyan Guo

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.113134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Xiaohua Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The Second Hospital of Hebei Medical University, Heping West Road No. 215, Shijiazhuang 050000, China. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Janus Kinase 2, Isoproterenol, Oxidative Stress. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Inflammation and oxidative stress have drawn more and more interest in the realm of cardiovascular disease. In many different disorders, IL-37 acts as an anti-inflammatory and suppressor of inflammation. This study aimed to investigate whether IL-37 could alleviate cardiac hypertrophy by reducing inflammation and oxidative stress. METHODS: In vivo, a cardiac hypertrophy model was induced by 14 d of daily isoproterenol (ISO, 30 mg/kg/d) injection, followed by weeks of treatment with recombinant human IL-37 (1000 ng/animal), administered three times weekly. Assessments concentrated on markers of inflammation and oxidative stress, apoptosis, myocardial disease, and cardiac shape and function. In vitro, neonatal rat cardiomyocytes (NRCMs) were subjected to ISO (10 µM) to establish a cardiomyocytes hypertrophy model. Subsequent IL-37 treatment (100 ng/ml) was applied to determine its cardioprotective efficacy and to elucidate further the underlying mechanisms involved. RESULTS: Significant cardioprotective benefits of IL-37 were seen (in vitro as well as in vivo), primarily through the reduction of oxidative stress, inflammation, apoptosis, and heart hypertrophy markers. Furthermore, IL-37 treatment was associated with a decrease in JAK2 and STAT3 phosphorylation. It is interesting to note that WP1066, a JAK2/STAT3 inhibitor, exhibited antioxidant and anti-inflammatory properties comparable to IL-37, as well as synergistic effects when mixed with the latter. CONCLUSION: ISO-induced cardiac hypertrophy is lessened by IL-37 through the reduction of oxidative stress and inflammation. Additionally, the effects of IL-37 are closely related to inactivation of the JAK2/STAT3 signaling pathway. It is anticipated that IL-37 will one day be used to treat cardiovascular illnesses such as heart hypertrophy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorJanus Kinase 2IsoproterenolOxidative StressCardiomegalySignal TransductionInterleukin-1Myocytes, CardiacRats, Sprague-DawleyAnimalsRatsMaleHumansCells, CulturedAnti-Inflammatory AgentsInflammationApoptosisCardiotonic AgentsDisease Models, Animal

Stichwörter der Autor:innen

Cardiac hypertrophyIL-37Inflammation and oxidative stressJAK2/STAT3

Substanzen

STAT3 Transcription FactorJanus Kinase 2IsoproterenolInterleukin-1IL37 protein, humanAnti-Inflammatory AgentsJak2 protein, ratStat3 protein, ratCardiotonic Agents

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, The Second Hospital of Hebei Medical University, Heping West Road No. 215, Shijiazhuang 050000, China.
  • Department of Cardiovascular Medicine, The Second Hospital of Hebei Medical University, Heping West Road No. 215, Shijiazhuang 050000, China; Hebei Key Laboratory of Laboratory Medicine, The Second Hospital of Hebei Med…

Zitieren

APA

Guo, X., Wang, P., Wei, H., Yan, J., Zhang, D., Qian, Y., & Guo, B. (2024). Interleukin(IL)-37 attenuates isoproterenol (ISO)-induced cardiac hypertrophy by suppressing JAK2/STAT3-signaling associated inflammation and oxidative stress. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113134

Vancouver

Guo X, Wang P, Wei H, Yan J, Zhang D, Qian Y, et al. Interleukin(IL)-37 attenuates isoproterenol (ISO)-induced cardiac hypertrophy by suppressing JAK2/STAT3-signaling associated inflammation and oxidative stress. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113134

BibTeX
@article{Guo2024,
  author = {Guo, Xiaohua and Wang, Pengfei and Wei, Huiqing and Yan, Jie and Zhang, Donglei and Qian, Yuxing and Guo, Bingyan},
  title = {Interleukin(IL)-37 attenuates isoproterenol (ISO)-induced cardiac hypertrophy by suppressing JAK2/STAT3-signaling associated inflammation and oxidative stress},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.113134}
}
Kostenlos starten →